Morphosys holt Amgen-Manager in den Vorstand


Morphosys holt Amgen-Manager in den Vorstand
Morphosys holt Amgen-Manager in den Vorstand: Das Biotech-Unternehmen Morphosys meldet eine Personalie im Vorstand. Mit Wirkung zum 5. Mai wird Roland Wandeler zum neuen Vertriebsvorstand der …


Media and investors | MorphoSys AG
MorphoSys’ vision MorphoSys is committed to develop exceptional new treatments for patients suffering from serious diseases. A leader in the field of therapeutic antibodies today, MorphoSys is driven by the ambition of creating the most valuable pipeline of biopharmaceuticals in the biotechnology industry.


Morphosys holt Amgen-Manager in den Vorstand – 4investors-News
Das Biotech-Unternehmen Morphosys meldet eine Personalie im Vorstand. Mit Wirkung zum 5. Mai wird Roland Wandeler zum neuen Vertriebsvorstand der Gesellschaft berufen. Der Manager soll damit global f


MorphoSys events | MorphoSys AG
One of the main goals of the corporate communications function at MorphoSys is to inform stakeholders about the achievements and the developments within the company in an open and timely manner. Please see our full program listings for further details.


Morphosys holt Amgen-Manager in den Vorstand – 22.04.2020
Morphosys holt Amgen-Manager in den Vorstand Das Biotech-Unternehmen Morphosys meldet eine Personalie im Vorstand. Mit Wirkung zum 5. Mai wird Roland Wandeler zum neuen Vertriebsvorstand der …


PDF Management Board of MorphoSys AG
Management Board of MorphoSys AG. jens holstein chiEf finAnciAl officEr “The progress in our product pipeline was also reflected in a very success-ful year financially. We intend to use our financial resources in order to seize any opportunities which may arise, whether in-licensing of com-


MorphoSys Announces Change in Executive Management Board …
Dr. Gerald Möller, Chairman of the Supervisory Board of MorphoSys AG, commented: “On behalf of both the Supervisory Board and the Executive Management Board, I would like to express my heartfelt thanks to Dave Lemus for his commitment to helping build MorphoSys over the past thirteen years.


Senior Management Group der MorphoSys AG | MorphoSys
Silvia Dermietzel Head of [no-dd_report_glossary]human resources[/no-dd_report_glossary] Dr. Gabriele Elbl Head of Regulatory Affairs. Dr. Markus Enzelberger Head of Discovery Alliances & Technologies


MorphoSys’s CSO Marlies Sproll Takes Temporary Leave …
About MorphoSys: MorphoSys developed HuCAL, the most successful antibody library technology in the pharmaceutical industry. By successfully applying this and other patented technologies, MorphoSys has become a leader in the field of therapeutic antibodies, one of the fastest-growing drug classes in human healthcare.


MorphoSys Announces New Management Appointments | MorphoSys AG
About MorphoSys: MorphoSys developed HuCAL, the most successful antibody library technology in the pharmaceutical industry. By successfully applying this and other patented technologies, MorphoSys has become a leader in the field of therapeutic antibodies, one of the fastest-growing drug classes in human healthcare.